Exploring New Opportunities through the Global Business Innovation Programme
Victor Harabari, co-founder of CardioCrown, recently participated in the Global Business Innovation Programme (GBIP), an initiative designed to foster collaboration between UK SMEs and the Irish MedTech sector. This comprehensive program included a five-day innovation visit to Ireland, where Victor Harabari engaged with local hospitals, research institutions, and life sciences companies.
The GBIP has had a profoundly positive impact on CardioCrown’s relationships within the Irish MedTech landscape. By facilitating valuable connections and providing insights into the unique challenges and opportunities in the Irish market, the program has enabled CardioCrown to refine its strategies for collaboration and innovation.
Victor shared, “Participating in the GBIP was a pivotal experience for us. The connections we made in Ireland have opened doors to exciting opportunities for collaboration and innovation in the MedTech space. The insights gained from engaging with local hospitals and life sciences companies are invaluable as we continue to expand our reach and impact within the healthcare sector.”
The Irish MedTech market, valued at approximately €12.6 billion, is rapidly growing, driven by advancements in technology and a wider adoption of medical innovations. With more than 300 life sciences companies and numerous research centres, Ireland provides an ideal environment for developing groundbreaking health technologies.
Through the GBIP, CardioCrown has not only strengthened its network but also positioned itself as a key player in the evolving landscape of health and technology collaboration. This engagement marks a significant step forward in CardioCrown’s mission to make a meaningful impact in the MedTech industry.
